A7A-17076-99169
5 vaccinations
12 coded responses
53 check-ins
12 free-text entries
5 call cases
- Sex
- Male
- Age at first dose
- 66+
- ZIP prefix
- 840 / UT
- Registered
- 2021-02-01
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-02-01
Registered in v-safe
-
2021-02-01
Dose 1 — Pfizer-BioNTech
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-04
- 2021-02-05
- 2021-02-06
- 2021-02-07
- 2021-02-08
- 2021-02-15
-
2021-02-22
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-08
- 2021-03-15
- 2021-03-22
- 2021-03-29
- 2021-04-05
-
2021-05-24
Survey response — 3 months, dose 2MedDRA: Dizziness — Feeling: Good · Be unable to do your normal daily activitiesFree text: I had a dizzy spell last week and had to have help getting into the house. I have had mild dizziness off and on since but not as severe as the first time.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-08-25
Survey response — 6 months, dose 2MedDRA: Prostatitis — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Prostatitis, treated with antibiotics.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-25
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-31
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-09-30
- 2021-10-01
- 2021-10-02
-
2021-10-03
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
-
2021-10-04
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
-
2021-10-09
Survey response — day 7, dose 3MedDRA: No adverse event — Feeling: GoodFree text: NoneMedDRA releases: 2024-11 · check-in free text available
- 2021-10-14
- 2021-10-21
- 2021-10-28
- 2021-11-04
- 2021-11-11
-
2021-12-30
Survey response — 3 months, dose 3MedDRA: Dizziness, Nausea — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Light-Headed NauseousMedDRA releases: 2024-11 · check-in free text available
-
2021-12-30
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-01-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-01-04
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-03-31
Survey response — 6 months, dose 3MedDRA: Atrial fibrillation, Pre-existing disease, Surgery — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, HospitalizationFree text: Symptoms: Undergoing preparation for a surgical procedure to remove cancerous tissue. Also will start on meds for A-Fib after the surgery. · Healthcare visit (other): Minor surgery for biopsyMedDRA releases: 2024-11 · check-in free text available
-
2022-03-31
Report sent to call center — 6 months, dose 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Hospitalization · 1 call case(s)
-
2022-04-04
Call successfulDoes not wish to fill out VAERS report
-
2022-05-02
Dose 4 — Pfizer-BioNTech
-
2022-05-15
Survey response — day 7, dose 4MedDRA: No adverse event — Feeling: GoodFree text: NoMedDRA releases: 2024-11 · check-in free text available
- 2022-05-16
- 2022-05-23
- 2022-05-31
- 2022-06-06
- 2022-06-13
-
2022-08-01
Survey response — 3 months, dose 4MedDRA: Cautery to nose, Epistaxis — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visitFree text: Several episodes severe bloody nose which led to cauterization to get it to stop bleeding.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-01
Report sent to call center — 3 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
- 2022-08-02
-
2022-09-07
Dose 5 — Pfizer-BioNTech
- 2022-09-26
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
-
2022-12-07
Survey response — 3 months, dose 5MedDRA: Nasopharyngitis, Sinusitis, Unevaluable event — Feeling: Fair · Get care from a doctor or other healthcare professional · HospitalizationFree text: Symptoms: Bad cold or sinus infections · Healthcare visit (other): Appt tomorrowMedDRA releases: 2024-11 · check-in free text available
-
2022-12-07
Report sent to call center — 3 months, dose 5Get care from a doctor or other healthcare professionalHospitalization · 1 call case(s)
-
2022-12-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-08
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-03-08
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-01 | Pfizer-BioNTech | |
| 2 | 2021-02-22 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
| 4 | 2022-05-02 | Pfizer-BioNTech | No |
| 5 | 2022-09-07 | Pfizer-BioNTech | No |
Call center
5 call center cases
5 successful
Free text
Release 8 — 3 months, dose 2
Symptoms: I had a dizzy spell last week and had to have help getting into the house. I have had mild dizziness off and on since but not as severe as the first time.
Release 9 — 6 months, dose 2
Symptoms: Prostatitis, treated with antibiotics.
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): No
Systemic reaction (other): None
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): None
Systemic reaction (other): None
Release 10 — day 7, dose 3
Systemic reaction (other): None
Release 10 — 3 months, dose 3
Symptoms: Light-Headed Nauseous
Release 11 — 6 months, dose 3
Symptoms: Undergoing preparation for a surgical procedure to remove cancerous tissue. Also will start on meds for A-Fib after the surgery.
Healthcare visit (other): Minor surgery for biopsy
Release 11 — day 7, dose 4
Systemic reaction (other): No
Release 12 — 3 months, dose 4
Symptoms: Several episodes severe bloody nose which led to cauterization to get it to stop bleeding.
Release 12 — 3 months, dose 5
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Surgery | · | · | ✓ |
| HCVO | Unevaluable event | · | · | ✓ |
| SD | Atrial fibrillation | · | · | ✓ |
| SD | Cautery to nose | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Epistaxis | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Prostatitis | ✓ | · | ✓ |
| SD | Sinusitis | · | · | ✓ |
| SRO | No adverse event | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release